{
  "agent_name": "evidence_presenter",
  "pdf_name": "CDC_Influenza_vaccines",
  "started_at": "2025-07-30T22:09:43.807657",
  "completed_at": "2025-07-30T22:09:43.808025",
  "status": "completed",
  "error": null,
  "config": {
    "disable_cache": true,
    "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines."
  }
}